Recombinant multi-species MEK5/MAP2K5 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine MEK5/MAP2K5 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The protein encoded by this gene is a dual specificity protein kinase that belongs to the MAP kinase kinase family. This kinase specifically interacts with and activates MAPK7/ERK5. This kinase itself can be phosphorylated and activated by MAP3K3/MEKK3, as well as by atypical protein kinase C isoforms (aPKCs). The signal cascade mediated by this kinase is involved in growth factor stimulated cell proliferation and muscle cell differentiation. Three alternatively spliced transcript variants of this gene encoding distinct isoforms have been described. [provided by RefSeq, May 2011]
The Alternative Names of target: Dual specificity mitogen-activated protein kinase kinase 5,HsT17454,MAP kinase kinase 5,MAP2K5,MAPK/ERK kinase 5 (MEK 5),MAPKK 5,MAPKK5,MEK5,Map2k5,Mapkk5,Mek5,PRKMK5,Prkmk5

Target products collectionGo to MEK5/MAP2K5 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-T17143-Ag-1/ GM-Tg-hg-T17143-Ag-2 Human MEK5/MAP2K5 protein Human
GM-Tg-rg-T17143-Ag-1/ GM-Tg-rg-T17143-Ag-2 Rat MEK5/MAP2K5 protein Rat
GM-Tg-mg-T17143-Ag-1/ GM-Tg-mg-T17143-Ag-2 Mouse MEK5/MAP2K5 protein Mouse
GM-Tg-cynog-T17143-Ag-1/ GM-Tg-cynog-T17143-Ag-2 Cynomolgus/Rhesus macaque MEK5/MAP2K5 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-T17143-Ag-1/ GM-Tg-felg-T17143-Ag-2 Feline MEK5/MAP2K5 protein Feline
GM-Tg-cang-T17143-Ag-1/ GM-Tg-cang-T17143-Ag-2 Canine MEK5/MAP2K5 protein Canine
GM-Tg-bovg-T17143-Ag-1/ GM-Tg-bovg-T17143-Ag-2 Bovine MEK5/MAP2K5 protein Bovine
GM-Tg-equg-T17143-Ag-1/ GM-Tg-equg-T17143-Ag-2 Equine MEK5/MAP2K5 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-T17143-Ag-1/ GM-Tg-hg-T17143-Ag-2; GM-Tg-rg-T17143-Ag-1/ GM-Tg-rg-T17143-Ag-2;
GM-Tg-mg-T17143-Ag-1/ GM-Tg-mg-T17143-Ag-2; GM-Tg-cynog-T17143-Ag-1/ GM-Tg-cynog-T17143-Ag-2;
GM-Tg-felg-T17143-Ag-1/ GM-Tg-felg-T17143-Ag-2; GM-Tg-cang-T17143-Ag-1/ GM-Tg-cang-T17143-Ag-2;
GM-Tg-bovg-T17143-Ag-1/ GM-Tg-bovg-T17143-Ag-2; GM-Tg-equg-T17143-Ag-1/ GM-Tg-equg-T17143-Ag-2
Products Name MEK5/MAP2K5 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name MEK5/MAP2K5
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine MEK5/MAP2K5 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.